N⁶-methyladenosine modification of CENPK mRNA by ZC3H13 promotes cervical cancer stemness and chemoresistance.

"Declarations Ethics approval and consent to participatePatient consent and ethics approval were obtained from the Ethics Committee of Shanghai Outdo Biotech Corporation (YB M-05–02). The procedures used in this study adhere to the tenets of the Declaration of Helsinki. The Institutional Animal Ethical Committee, Experimental Animal Center of Fujian Medical University and Fujian Cancer Hospital approved the protocols for animal studies (K2020-036–01). Consent for publicationNot applicable. Availability of data and materialsThe datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request. Competing  interestsThe authors declare that they have no competing interests."

"Funding This study was supported by the Joint Funds for the Innovation of Science and Technology Program of Fujian Province, China (2018Y9110), the Natural Science Foundation of Fujian Province, China, (2020J011126), and the China Postdoctoral Science Foundation (2021T140468)."